Senior Lecturer in Health Economics
Queen Mary University of London (United Kingdom)
I am a health economist based in the Health Economics and Policy Research Unit, in the Wolfson Institute of Population Health (WIPH). I joined Queen Mary University of London (QMUL) in 2023 as a Senior Lecturer. Prior to joining QMUL, I worked at the University of Oxford for 18 years, first as a Researcher, then a Senior Researcher. At WIPH, my role is to lead on work on the health economic aspects of precision diagnosis and treatment and translation research, across the Barts Biomedical Research Centre.
I hold a BA in Economics (University of Nottingham), an MA in Economic Development and Policy Analysis (University of Nottingham) and a DPhil in Health Economics (University of Oxford). My doctoral research investigated issues related to the economic analysis of genomic diagnostic technologies for multifactorial genetic diseases in the UK NHS.
My research focuses on applying economic methods to quantify the value of precision medicine for stakeholders in the health system. I have a particular interest in understanding the costs and benefits of genome sequencing in people with cancer and rare diseases, in particular newborns. I have undertaken and published economic evaluations, outcomes studies, microcosting analyses, and discrete choice experiments in this space, working alongside national population sequencing initiatives such as the Genomics England 100,000 Genomes Project. I also curate the Health Economics and Genomics blog (https://healtheconomicsandgenomics.com/).
Disclosure information not submitted.
Tuesday, June 11, 2024
3:30 PM – 5:00 PM ET